Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

METHODS AND COMPOSITIONS FOR DRM, A NUCLEAR PROTEIN WITH CELL CYCLE REGULATING ACTIVITY

  • Read more about METHODS AND COMPOSITIONS FOR DRM, A NUCLEAR PROTEIN WITH CELL CYCLE REGULATING ACTIVITY
US Application 60/079,440
Filed on 1998-03-26

Novel Thiolesters and Uses Thereof

  • Read more about Novel Thiolesters and Uses Thereof
US Application 60/089,842
Filed on 1998-06-19

Human Monoclonal Antibodies to HIV-Envelope Glycoprotein GP120

  • Read more about Human Monoclonal Antibodies to HIV-Envelope Glycoprotein GP120
US Application 60/141,701
Filed on 1999-06-30

cDNA Encoding a Gene BOG(Bst Over-Expressed Gene) and Its Protein Product

  • Read more about cDNA Encoding a Gene BOG(Bst Over-Expressed Gene) and Its Protein Product
US Application 60/079,567
Filed on 1998-07-02

MUCOSAL CYTOTOXIC T LYMPHOCYTE RESPONSES

  • Read more about MUCOSAL CYTOTOXIC T LYMPHOCYTE RESPONSES
US Application 60/074,894
Filed on 1998-02-17

USE OF CONSTITUTIVE TRANSPORT ELEMENTS TO CONTROL THE HOST RANGE OF RETROVIRAL VECTORS

  • Read more about USE OF CONSTITUTIVE TRANSPORT ELEMENTS TO CONTROL THE HOST RANGE OF RETROVIRAL VECTORS
US Application 60/094,535
Filed on 1998-07-29

Agents That Bind To And Inhibit Human Cytochrome P450 1A2

  • Read more about Agents That Bind To And Inhibit Human Cytochrome P450 1A2
US Application 60/093,913
Filed on 1998-07-23

METHODS AND COMPOSITIONS OF CHEMOKINE-TUMOR ANTIGEN FUSION PROTEINS AS CANCER VACCINES

  • Read more about METHODS AND COMPOSITIONS OF CHEMOKINE-TUMOR ANTIGEN FUSION PROTEINS AS CANCER VACCINES
US Application 60/077,745
Filed on 1998-03-12

Method for Deoxygenation of Nucleoside Secondary Alcohols

  • Read more about Method for Deoxygenation of Nucleoside Secondary Alcohols
US Application 60/112,327
Filed on 1998-12-15

MONOCLONAL ANTIBODY AGAINST MET PROTEIN.

  • Read more about MONOCLONAL ANTIBODY AGAINST MET PROTEIN.
US Application 60/168,835
Filed on 1999-12-03

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 210
  • Page 211
  • Page 212
  • Page 213
  • Page 214
  • Page 215
  • Page 216
  • Page 217
  • Page 218
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health